Precancer and in-situ lesions

Actinic keratosis and Bowen disease

Not every rough patch is cancer, but persistent photodamage and carcinoma in situ need proper assessment, especially when a lesion thickens, bleeds or changes.

Actinic keratosis histology
Actinic keratosis: atypical keratinocytes do not involve the full epidermal thickness.Mikael Häggström, CC0 1.0.
Dermoscopy of Bowen disease
Bowen disease - dermoscopy. Surface and vascular patterns can support suspicion, but biopsy is still required when invasion is a concern.Wikimedia Commons, CC BY-SA 4.0.
Bowen disease histology
Bowen disease is squamous cell carcinoma in situ with full-thickness epidermal atypia.KGH / Wikimedia Commons, CC BY-SA 3.0.

Actinic keratosis is more than a dry spot

It is a marker of chronic ultraviolet damage and often reflects a wider field of altered keratinocytes.

Bowen disease

This is squamous cell carcinoma in situ: abnormal cells remain within the epidermis. The key question is whether there is any invasive component.

Biopsy becomes especially important when: the lesion becomes firm or painful, ulcerates or bleeds, grows rapidly, is markedly hyperkeratotic, or does not respond to treatment.

Treatment

Actinic keratosis can be treated lesion by lesion or as a field. Bowen disease treatment depends on site, size, risk of invasion/recurrence and the need for reliable margin control.

European approach

Current guidance places actinic keratosis within the broader concept of UV-induced field cancerization.

European guideline 2024.